HSBA

1,179

-0.05%↓

LLOY

92.9

+0.74%↑

BARC

382.75

+0.41%↑

LSE

8,454

+0.64%↑

STAN

1,572

+0.77%↑

HSBA

1,179

-0.05%↓

LLOY

92.9

+0.74%↑

BARC

382.75

+0.41%↑

LSE

8,454

+0.64%↑

STAN

1,572

+0.77%↑

HSBA

1,179

-0.05%↓

LLOY

92.9

+0.74%↑

BARC

382.75

+0.41%↑

LSE

8,454

+0.64%↑

STAN

1,572

+0.77%↑

HSBA

1,179

-0.05%↓

LLOY

92.9

+0.74%↑

BARC

382.75

+0.41%↑

LSE

8,454

+0.64%↑

STAN

1,572

+0.77%↑

HSBA

1,179

-0.05%↓

LLOY

92.9

+0.74%↑

BARC

382.75

+0.41%↑

LSE

8,454

+0.64%↑

STAN

1,572

+0.77%↑

Search

Scottish Mortgage Investment Trust PLC

Suletud

SektorRahandus

1,163.5 -0.09

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

1152

Max

1177.5

Põhinäitajad

By Trading Economics

Sissetulek

1.7B

2.7B

Müük

1.6B

2.7B

P/E

Sektori keskmine

3.87

54.048

Aktsiakasum

2.29

Dividenditootlus

0.37

Kasumimarginaal

99.398

EBITDA

1.6B

2.7B

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

0.37%

4.84%

Järgmine tulemuste avaldamine

21. mai 2026

Turustatistika

By TradingEconomics

Turukapital

930M

13B

Eelmine avamishind

1163.59

Eelmine sulgemishind

1163.5

Uudiste sentiment

By Acuity

50%

50%

160 / 441 Pingereas Finance

Scottish Mortgage Investment Trust PLC Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

23. märts 2026, 23:47 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23. märts 2026, 22:55 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23. märts 2026, 21:51 UTC

Omandamised, ülevõtmised, äriostud

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23. märts 2026, 23:59 UTC

Market Talk

Global Equities Roundup: Market Talk

23. märts 2026, 23:59 UTC

Market Talk

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23. märts 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23. märts 2026, 23:37 UTC

Market Talk

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23. märts 2026, 22:42 UTC

Market Talk
Uudisväärsed sündmused

Global Equities Roundup: Market Talk

23. märts 2026, 22:42 UTC

Market Talk
Uudisväärsed sündmused

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23. märts 2026, 22:40 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23. märts 2026, 22:23 UTC

Market Talk

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23. märts 2026, 22:22 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23. märts 2026, 22:21 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23. märts 2026, 22:21 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23. märts 2026, 22:20 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23. märts 2026, 22:20 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23. märts 2026, 22:19 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23. märts 2026, 22:19 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23. märts 2026, 22:18 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23. märts 2026, 22:15 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23. märts 2026, 22:08 UTC

Market Talk

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23. märts 2026, 21:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23. märts 2026, 21:42 UTC

Market Talk

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23. märts 2026, 21:32 UTC

Tulu

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23. märts 2026, 21:32 UTC

Tulu

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23. märts 2026, 21:32 UTC

Tulu

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23. märts 2026, 21:10 UTC

Uudisväärsed sündmused

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23. märts 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

23. märts 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

23. märts 2026, 20:50 UTC

Market Talk
Tulu
Uudisväärsed sündmused

Basic Materials Roundup: Market Talk

Võrdlus sarnastega

Hinnamuutus

Scottish Mortgage Investment Trust PLC Prognoos

Sentiment

By Acuity

160 / 441 Pingereas Rahandus

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Scottish Mortgage Investment Trust PLC

Scottish Mortgage Investment Trust PLC is a United Kingdom-based investment trust. The Company’s investment objective is to maximize total return from a portfolio of long-term investments chosen on a global basis enabling the Company to provide capital and dividend growth. The Company invests in listed and private company securities and makes other investments so as to achieve its investment objective to maximize total return from a portfolio of long-term investments. It invests in various sectors, including consumer discretionary, technology, healthcare, industrials, financials, consumer staples, basic materials and energy. The Company invests in various geographical segments, including North America, Europe, Asia, South America, and Africa and Middle East. The Company’s Alternative Investment Fund Manager (AIFM) is Baillie Gifford & Co Limited.
help-icon Live chat